IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 187 filers reported holding IMMUNOGEN INC in Q3 2020. The put-call ratio across all filers is 0.68 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,827,000 | +14.2% | 349,000 | -9.0% | 0.00% | 0.0% |
| Q4 2020 | $2,475,000 | +76.9% | 383,709 | -1.3% | 0.00% | +100.0% |
| Q3 2020 | $1,399,000 | -21.1% | 388,721 | +0.8% | 0.00% | -50.0% |
| Q2 2020 | $1,774,000 | +57.8% | 385,632 | +17.0% | 0.00% | +100.0% |
| Q1 2020 | $1,124,000 | -30.1% | 329,664 | +4.6% | 0.00% | 0.0% |
| Q4 2019 | $1,609,000 | +192.5% | 315,164 | +38.8% | 0.00% | 0.0% |
| Q3 2019 | $550,000 | +32.5% | 227,100 | +18.8% | 0.00% | – |
| Q2 2019 | $415,000 | -56.1% | 191,200 | -45.2% | 0.00% | -100.0% |
| Q1 2019 | $946,000 | -48.7% | 348,900 | -9.1% | 0.00% | -66.7% |
| Q4 2018 | $1,843,000 | +5.4% | 383,986 | +108.1% | 0.00% | +50.0% |
| Q3 2018 | $1,748,000 | +22.8% | 184,531 | +26.1% | 0.00% | 0.0% |
| Q2 2018 | $1,424,000 | -21.4% | 146,302 | -15.0% | 0.00% | -33.3% |
| Q1 2018 | $1,812,000 | +43.4% | 172,204 | -12.6% | 0.00% | +50.0% |
| Q4 2017 | $1,264,000 | +48.2% | 197,132 | +76.8% | 0.00% | +100.0% |
| Q3 2017 | $853,000 | +7.6% | 111,500 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $793,000 | +83.6% | 111,500 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $432,000 | +82.3% | 111,500 | -4.1% | 0.00% | – |
| Q4 2016 | $237,000 | -24.0% | 116,300 | 0.0% | 0.00% | -100.0% |
| Q3 2016 | $312,000 | -18.5% | 116,300 | -6.4% | 0.00% | 0.0% |
| Q2 2016 | $383,000 | -64.9% | 124,300 | -3.0% | 0.00% | -50.0% |
| Q1 2016 | $1,092,000 | -40.8% | 128,200 | -5.7% | 0.00% | -33.3% |
| Q4 2015 | $1,846,000 | +41.3% | 136,000 | 0.0% | 0.00% | +50.0% |
| Q3 2015 | $1,306,000 | -33.2% | 136,000 | 0.0% | 0.00% | -33.3% |
| Q2 2015 | $1,956,000 | +123.8% | 136,000 | 0.0% | 0.00% | +200.0% |
| Q1 2015 | $874,000 | 0.0% | 136,000 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $874,000 | -43.3% | 136,000 | -6.5% | 0.00% | -50.0% |
| Q3 2014 | $1,541,000 | -8.9% | 145,500 | +2.0% | 0.00% | 0.0% |
| Q2 2014 | $1,691,000 | -10.1% | 142,700 | +4.9% | 0.00% | -33.3% |
| Q1 2014 | $1,882,000 | -9.2% | 136,000 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $2,073,000 | -12.8% | 136,000 | -2.6% | 0.00% | -25.0% |
| Q3 2013 | $2,376,000 | +33.1% | 139,600 | +29.7% | 0.00% | 0.0% |
| Q2 2013 | $1,785,000 | – | 107,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,906,962 | $69,914,000 | 3.04% |
| Fernwood Investment Management, LLC | 224,500 | $1,439,000 | 0.77% |
| Telemetry Investments, L.L.C. | 272,000 | $1,744,000 | 0.66% |
| Schonfeld Strategic Advisors LLC | 865,356 | $5,547,000 | 0.45% |
| Virtus ETF Advisers LLC | 53,977 | $346,000 | 0.43% |
| Endurant Capital Management LP | 210,800 | $1,351,000 | 0.41% |
| SPHERA FUNDS MANAGEMENT LTD. | 500,000 | $3,205,000 | 0.38% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 113,216 | $726,000 | 0.37% |
| Orbimed Advisors | 2,834,126 | $18,167,000 | 0.23% |
| PINNACLE ASSOCIATES LTD | 1,322,231 | $8,476,000 | 0.16% |